BENZALKONIUM CHLORIDE 0.13% and ARTHROPATHY

95 reports of this reaction

2.8% of all BENZALKONIUM CHLORIDE 0.13% reports

#19 most reported adverse reaction

Overview

ARTHROPATHY is the #19 most commonly reported adverse reaction for BENZALKONIUM CHLORIDE 0.13%, manufactured by Meijer, Inc.. There are 95 FDA adverse event reports linking BENZALKONIUM CHLORIDE 0.13% to ARTHROPATHY. This represents approximately 2.8% of all 3,369 adverse event reports for this drug.

Patients taking BENZALKONIUM CHLORIDE 0.13% who experience arthropathy should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ARTHROPATHY95 of 3,369 reports

ARTHROPATHY is a less commonly reported adverse event for BENZALKONIUM CHLORIDE 0.13%, but still significant enough to appear in the safety profile.

Other Side Effects of BENZALKONIUM CHLORIDE 0.13%

In addition to arthropathy, the following adverse reactions have been reported for BENZALKONIUM CHLORIDE 0.13%:

Other Drugs Associated with ARTHROPATHY

The following drugs have also been linked to arthropathy in FDA adverse event reports:

ABATACEPTACETAMINOPHEN AND CODEINEACTIVATED CHARCOALADALIMUMAB AATYADALIMUMAB ADAZADALIMUMAB FKJPALENDRONATE SODIUMBENZALKONIUM CHLORIDECAFFEINECAFFEINE CITRATECALCIUM GLUCONATECERTOLIZUMAB PEGOLCETIRIZINE HYDROCHLORIDE ALLERGYCETIRIZINE HYDROCHLORIDE TABLETSCORTISONE ACETATEDESOXIMETASONEDICLOFENACDICLOFENAC SODIUMDICLOFENAC SODIUM 1%DICLOFENAC SODIUM TOPICAL

Frequently Asked Questions

Does BENZALKONIUM CHLORIDE 0.13% cause ARTHROPATHY?

ARTHROPATHY has been reported as an adverse event in 95 FDA reports for BENZALKONIUM CHLORIDE 0.13%. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ARTHROPATHY with BENZALKONIUM CHLORIDE 0.13%?

ARTHROPATHY accounts for approximately 2.8% of all adverse event reports for BENZALKONIUM CHLORIDE 0.13%, making it a notable side effect.

What should I do if I experience ARTHROPATHY while taking BENZALKONIUM CHLORIDE 0.13%?

If you experience arthropathy while taking BENZALKONIUM CHLORIDE 0.13%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

BENZALKONIUM CHLORIDE 0.13% Full ProfileAll Drugs Causing ARTHROPATHYMeijer, Inc. Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.